• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 279-293 of 1,014 results

2045 Exhibit: PDR 1999 Nolvadex

Document IPR2017-01910, No. 2045-159 Exhibit - PDR 1999 Nolvadex (P.T.A.B. Nov. 15, 2017)

cite Cite Document
Analyze

2027 Exhibit: Dukes 1994

Document IPR2017-01910, No. 2027-141 Exhibit - Dukes 1994 (P.T.A.B. Nov. 15, 2017)

cite Cite Document
Analyze

1030 Exhibit: White, Pharmacokinetic and Pharmacodynamic Considerations in An...

Document IPR2017-01910, No. 1030-30 Exhibit - White, Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization, 57 ANTIMICROBIAL AGENTS CHEMOTHERAPY 5802 2...

cite Cite Document
Analyze

1105 Exhibit: Powell, Compendium of Excipients for Parenteral Formulations, 52 PD...

Document IPR2017-01910, No. 1105-105 Exhibit - Powell, Compendium of Excipients for Parenteral Formulations, 52 PDA J PHARM SCI TECH 238 311 1998 (P.T.A.B. Aug. 4, 2017)

cite Cite Document
Analyze

2160 Exhibit: Huynh 1993

Document IPR2017-01910, No. 2160-275 Exhibit - Huynh 1993 (P.T.A.B. Nov. 15, 2017)

cite Cite Document
Analyze

1072 Exhibit: Spiegel Noseworthy, Use of Nonaqueous Solvents in Parenteral Prod...

Document IPR2017-01910, No. 1072-72 Exhibit - Spiegel Noseworthy, Use of Nonaqueous Solvents in Parenteral Products, 52 J PHARM SCIS 917 27 1963 (P.T.A.B. Aug. 4, 2017)

cite Cite Document
Analyze

2018 Exhibit: Morrow 1993

Document IPR2017-01910, No. 2018-132 Exhibit - Morrow 1993 (P.T.A.B. Nov. 15, 2017)

cite Cite Document
Analyze

2172 Exhibit: FDA Guidance 1999

Document IPR2017-01910, No. 2172-287 Exhibit - FDA Guidance 1999 (P.T.A.B. Nov. 15, 2017)

cite Cite Document
Analyze

1017 Exhibit: AstraZenecas Preliminary Response in Mylan Pharms Inc v AstraZen...

Document IPR2017-01910, No. 1017-17 Exhibit - AstraZenecas Preliminary Response in Mylan Pharms Inc v AstraZeneca AB, Paper No 10, IPR2016 01325 PTAB Oct 6, 2016 (P.T.A.B. Aug. 4, 2017)

cite Cite Document
Analyze

1055 Exhibit: EP 0 346 014

Document IPR2017-01910, No. 1055-55 Exhibit - EP 0 346 014 (P.T.A.B. Aug. 4, 2017)

cite Cite Document
Analyze

2016 Exhibit: Howell 1992

Document IPR2017-01910, No. 2016-130 Exhibit - Howell 1992 (P.T.A.B. Nov. 15, 2017)

cite Cite Document
Analyze

1013 Exhibit: Declaration of Richard Bergstrom, PhD and Accompanying Exhibits

Document IPR2017-01910, No. 1013-13 Exhibit - Declaration of Richard Bergstrom, PhD and Accompanying Exhibits (P.T.A.B. Aug. 4, 2017)

cite Cite Document
Analyze

1094 Exhibit: Tse, Bioavailability of Parenteral Drugs I Intravenous and Intramuscu...

Document IPR2017-01910, No. 1094-94 Exhibit - Tse, Bioavailability of Parenteral Drugs I Intravenous and Intramuscular Doses, 34 J PARENTERAL DRUG ASSOCIATION 409 21 1980 (P.T.A.B. Aug. 4, 2...

cite Cite Document
Analyze

2042 Exhibit: AACR Journals Online

Document IPR2017-01910, No. 2042-156 Exhibit - AACR Journals Online (P.T.A.B. Nov. 15, 2017)

cite Cite Document
Analyze

1034 Exhibit: Finley, New Drug Being Tested in Breast Cancer Study, SAN ANTONI...

Document IPR2017-01910, No. 1034-34 Exhibit - Finley, New Drug Being Tested in Breast Cancer Study, SAN ANTONIO EXPRESS NEWS, Sept 20, 1997 (P.T.A.B. Aug. 4, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 19 20 21 22 23 ... >>